1. Home
  2. CRNX vs PVH Comparison

CRNX vs PVH Comparison

Compare CRNX & PVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$36.70

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo PVH Corp.

PVH

PVH Corp.

HOLD

Current Price

$74.38

Market Cap

3.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNX
PVH
Founded
2008
1881
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.6B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
CRNX
PVH
Price
$36.70
$74.38
Analyst Decision
Strong Buy
Buy
Analyst Count
8
16
Target Price
$76.75
$90.53
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
05-07-2026
06-03-2026
Dividend Yield
N/A
0.16%
EPS Growth
N/A
N/A
EPS
N/A
1.90
Revenue
$1,039,000.00
$8,950,200,000.00
Revenue This Year
$720.10
$1.89
Revenue Next Year
$184.67
$1.86
P/E Ratio
N/A
$37.91
Revenue Growth
N/A
3.44
52 Week Low
$25.83
$59.60
52 Week High
$57.99
$100.75

Technical Indicators

Market Signals
Indicator
CRNX
PVH
Relative Strength Index (RSI) 52.34 38.06
Support Level $33.14 $70.63
Resistance Level $44.89 $87.47
Average True Range (ATR) 1.63 3.38
MACD 0.29 -0.96
Stochastic Oscillator 68.55 26.75

Price Performance

Historical Comparison
CRNX
PVH

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

About PVH PVH Corp.

PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, roughly 1,400 standalone stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.

Share on Social Networks: